Previous research has associated decreased expression of PGRMC1 with advanced stages and poorer prognosis, and therefore has been proposed as a potential prognostic biomarker for HCC and various other cancers [32,67,68]. The gene discussed is PGRMC1; the disease is hepatocellular carcinoma.